ABL Bio is forecast to grow earnings and revenue by 49% and 11.1% per annum respectively. EPS is expected to grow by 47.2% per annum. Return on equity is forecast to be -12.8% in 3 years.
KOSDAQ:A298380 - Analysts future estimates and past financials data (KRW Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2028
86,000
-23,000
16,000
34,000
2
12/31/2027
114,540
1,750
19,400
21,380
5
12/31/2026
94,120
1,000
35,000
52,000
5
3/31/2026
90,321
-24,136
6,433
19,955
N/A
12/31/2025
79,350
-37,806
-61,924
-41,253
N/A
9/30/2025
88,437
-28,645
-54,641
-33,185
N/A
6/30/2025
94,931
-20,522
-44,776
-23,584
N/A
3/31/2025
27,631
-71,706
-95,079
-80,249
N/A
12/31/2024
33,403
-55,529
-78,461
-69,403
N/A
9/30/2024
32,321
-49,041
-81,451
-71,189
N/A
6/30/2024
32,955
-40,003
-73,541
-64,894
N/A
3/31/2024
33,103
-38,952
-67,776
-60,555
N/A
12/31/2023
65,547
-2,647
-34,206
-28,362
N/A
9/30/2023
67,446
-7,951
1,252
4,155
N/A
6/30/2023
97,254
23,608
5,534
8,498
N/A
3/31/2023
104,803
36,101
9,863
12,230
N/A
12/31/2022
67,301
3,209
69,746
72,132
N/A
9/30/2022
57,994
4,352
43,645
44,605
N/A
12/31/2021
5,332
-43,558
-41,871
-40,605
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A298380 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.1%).
Earnings vs Market: A298380 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: A298380 is expected to become profitable in the next 3 years.
Revenue vs Market: A298380's revenue (11.1% per year) is forecast to grow slower than the KR market (16.6% per year).
High Growth Revenue: A298380's revenue (11.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A298380 is forecast to be unprofitable in 3 years.
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/18 01:57
End of Day Share Price
2026/06/18 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ABL Bio Inc. is covered by 4 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.